Home » Stocks » TELA

TELA Bio, Inc. (TELA)

Stock Price: $14.80 USD 0.23 (1.58%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 213.60M
Revenue (ttm) 17.41M
Net Income (ttm) -28.48M
Shares Out 14.42M
EPS (ttm) -2.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $14.80
Previous Close $14.57
Change ($) 0.23
Change (%) 1.58%
Day's Open 14.34
Day's Range 14.00 - 14.80
Day's Volume 19,365
52-Week Range 5.39 - 22.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

MALVERN, Pa., Jan. 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new categ...

GlobeNewsWire - 2 weeks ago

Bruce Freedman, M.D. joins innovative MedTech company to advocate for more natural surgical hernia mesh options

GlobeNewsWire - 1 month ago

MALVERN, Pa., Nov. 24, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue r...

Seeking Alpha - 2 months ago

TELA Bio, Inc. (TELA) CEO Tony Koblish on Q3 2020 Results - Earnings Call Transcript

Benzinga - 2 months ago

Shares of TELA Bio (NASDAQ:TELA) were flat after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 97.65% over the past year to ($0.53), whic...

GlobeNewsWire - 2 months ago

MALVERN, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue r...

PRNewsWire - 2 months ago

MALVERN, Pa., Nov. 9, 2020 /PRNewswire/ -- TELA Bio, Inc. ("TELA"), an innovative medtech company focused on solving the unmet needs in soft-tissue reconstruction, announced today that it will...

GlobeNewsWire - 3 months ago

MALVERN, Pa., Oct. 21, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new c...

GlobeNewsWire - 3 months ago

MALVERN, Pa., Sept. 25, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissu...

GlobeNewsWire - 4 months ago

MALVERN, Pa., Sept. 02, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissu...

Seeking Alpha - 5 months ago

TELA Bio, Inc. (TELA) CEO Tony Koblish on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

MALVERN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 5 months ago

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 5 months ago

MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new...

GlobeNewsWire - 6 months ago

MALVERN, Pa., July 09, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue...

GlobeNewsWire - 6 months ago

MALVERN, Pa., June 30, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue...

GlobeNewsWire - 6 months ago

MALVERN, Pa., June 25, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue...

GlobeNewsWire - 6 months ago

MALVERN, Pa., June 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue...

GlobeNewsWire - 7 months ago

MALVERN, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 7 months ago

MALVERN, Pa., June 15, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

Seeking Alpha - 8 months ago

TELA Bio, Inc. (TELA) CEO Antony Koblish on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 8 months ago

MALVERN, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cate...

GlobeNewsWire - 8 months ago

MALVERN, Pa., April 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a ne...

Seeking Alpha - 9 months ago

TELA Bio, Inc. (TELA) CEO Antony Koblish on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 11 months ago

MALVERN, Pa., Feb. 04, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 11 months ago

MALVERN, Pa., Jan. 29, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 1 year ago

MALVERN, Pa., Jan. 10, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

GlobeNewsWire - 1 year ago

MALVERN, Pa., Dec. 06, 2019 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new cat...

About TELA

TELA Bio, a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen... [Read more...]

Industry
Medical Devices
IPO Date
Nov 8, 2019
CEO
Antony Koblish
Employees
89
Stock Exchange
NASDAQ
Ticker Symbol
TELA
Full Company Profile

Financial Performance

In 2019, TELA Bio's revenue was $15.45 million, an increase of 86.68% compared to the previous year's $8.27 million. Losses were -$22.43 million, 6.32% more than in 2018.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for TELA Bio stock is "Buy." The 12-month stock price forecast is 20.00, which is an increase of 35.14% from the latest price.

Price Target
$20.00
(35.14% upside)
Analyst Consensus: Buy